Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis

Journal of Clinical Microbiology

Volumn 43, Issue 12, 2005, Pages 5916-5924

  Buffolano, Wilma ^a   Beghetto, Elisa ^b   Del Pezzo, Mariassunta ^a   Spadoni, Andrea ^b   Di Cristina, Manlio ^b   Petersen, Eskild ^c,d   Gargano, Nicola ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Kenton Laboratories   (Italy)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GENE PRODUCT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT ANTIGEN;

AMA1 GENE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD SAMPLING; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; HUMAN; INFANT; INFECTION RISK; M2AP GENE; MAJOR CLINICAL STUDY; MIC2 GENE; MIC3 GENE; MIC4 GENE; NONHUMAN; PERINATAL PERIOD; PLACENTA; PREGNANCY; PRIORITY JOURNAL; SAG1 GENE; TOXOPLASMA GONDII; VERTICAL TRANSMISSION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; POSTNATAL CARE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

TOXOPLASMA GONDII;

EID: 30744439329     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.12.5916-5924.2005     Document Type: Article

References (43)

1. Aubert, D., G. T. Maine, I. Villena, J. C. Hunt, L. Howard, M. Sheu, S. Brojanac, L. E. Chovan, S. F. Nowlan, and J. M. Pinon. 2000. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J. Clin. Microbiol. 38:1144-1150.
2. Beghetto, E., A. Pucci, O. Minenkova, A. Spadoni, L. Bruno, W. Buffolano, D. Soldati, F. Felici, and N. Gargano. 2001. Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries. Int. J. Parasitol. 31:1659-1668.
3. Beghetto, E., A. Spadoni, W. Buffolano, M. Del Pezzo, O. Minenkova, E. Pavoni, A. Pucci, R. Cortese, F. Felici, and N. Gargano. 2003. Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. Int. J. Parasitol. 33:163-173.
4. Beghetto, E., W. Buffolano, A. Spadoni, M. Del Pezzo, M. Di Cristina, O. Minenkova, E. Petersen, F. Felici, and N. Gargano. 2003. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J. Clin. Microbiol. 41:5414-5418.
5. Beghetto, E., H. V. Nielsen, P. Del Porto, W. Buffolano, S. Guglietta, F. Felici, E. Petersen, and N. Gargano. 2005. A combination of antigenic regions of Toxoplasma gondii microneme proteins induce protective immunity against oral infection with parasite cysts. J. Infect. Dis. 191:637-645.
6. Buffolano, W., M. Lappalainen, L. Hedman, F. Ciccimarra, M. Del Pezzo, R. Rescaldani, N. Gargano, and K. Hedman. 2004. Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 23:825-830.
7. Candolfi, E., M. H. Bessieres, P. Mart, B. Cimon, F. Gandilhon, H. Pelloux, and P. Thulliez. 1993. Determination of a new cut-off value for the diagnosis of congenital toxoplasmosis by detection of specific IgM in an enzyme immunoassay. Eur. J. Clin. Microbiol. Infect. Dis. 12:396-398.
8. Chumpitazi, B. F., A. Boussaid, H. Pelloux, C. Racinet, M. Bost, and A. Goullier-Fleuret. 1995. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods. J. Clin. Microbiol. 33:1479-1485.
9. Di Cristina, M., P. Del Porto, W. Buffolano, E. Beghetto, A. Spadoni, S. Guglietta, E. Piccolella, F. Felici, and N. Gargano. 2004. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microb. Infect. 6:164-171.
10. Dunn, D., M. Wallon, F. Peyron, E. Petersen, C. S. Peckham, and R. Gilbert. 1999. Mother to child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet 353:1829-1833.
11. Foulon, W., I. Villena, B. Stray-Pedersen, A. Decoster, M. Lappalainen, J. M. Pinon, P. A. Jenum, K. Hedman, and A. Naessens. 1999. Treatment of toxoplasmosis during pregnancy: a multicentcr study of impact on fetal transmission and children's sequelae at age 1 year. Am. J. Obstet. Gynaecol. 180:410-415.
12. Fricker-Hidalgo, H., H. Pelloux, C. Racinet, M. Bost, A. Goullier-Fleuret, and P. Ambroise-Thomas. 1996. Congenital toxoplasmosis: specific IgM in fetal blood, cord blood and in the newborn. Ann. Biol. Clin. 54:165-168.
13. Fricker-Hidalgo H., H. Pelloux, C. Racinet, I. Grefenstette, C. Bost-Bru, A. Goullier-Fleuret, and P. Ambroise-Thomas. 1998. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo, and in vitro cultures. Placenta 19:545-549.
14. Gay-Andrieu F., P. Marty, J. Pialat, G. Sournies, T. Drier de Laforte, and F. Peyron. 2003. Fetal toxoplasmosis and negative amniocentesis: necessity of an ultrasound follow-up. Prenat. Diagn. 23:558-560.
15. Gilbert, R., D. Dunn, M. Wallon, M. Hayde, A. Prusa, M. Lebech, T. Kortbeek, F. Peyron, A. Pollak, and E. Petersen. 2001. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol. Infect. 127:113-120.
16. Gilbert, R., L. Grass, and the European Multicentre Study on Congenital Toxoplasmosis. 2003. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Br. J. Obstet. Gynaecol. 110:112-120.
17. Gross, U., C. G. Luder, V. Hendgen, C. Heeg, I. Sauer, A. Weidner, D. Krezal, and G. Enders. 2000. Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis. J. Clin. Microbiol. 38:3619-3622.
18. Grover, C. M., P. Thulliez, J. S. Remington, and J. D. Boothroyd. 1990. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J. Clin. Microbiol. 28:2297-2301.
19. Guerina, N. G., H. W. Hsu, H. C. Meissner, J. H. Maguire, R. Lynfield, B. Stechenberg, I. Abroms, M. S. Pasternack, R. Hoff, R. B. Eaton, et al. 1994. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N. Engl. J. Med. 330:1858-1863.
20. Harning, D., J. Spenter, A. Metsis, J. Vuust, and E. Petersen. 1996. Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin. Diagn. Lab. lmmunol. 3:355-357.
21. Hohlfeld, P., F. Daffos, P. H. Thulliez, C. Aufrant, J. Couvreur, J. MacAleese, D. Descombey, and F. Forestier. 1989. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J. Pediatr. 115:765-769.
22. Hohlfeld, P., F. Daffos, J. M. Costa, P. H. Thuillez, F. Forestier, and M. Vidaud. 1994. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid. New Engl. J. Med. 331:695-699.
23. Jacobs, D., M. Vercammen, and E. Saman. 1999. Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin. Diagn. Lab. Immunol. 6:24-29.
24. Jenuni, P. A., M. Holberg-Petersen, K. K. Melby, and B. Stray-Pedersen. 1998. Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. The Norwegian experience. APMIS 106:680-686.
25. Koppe, J. G., D. H. Loewer-Sieger, and H. De Roever-Bonnet. 1986. Results of 20 year follow-up of congenital toxoplasmosis. Lancet 101:254-257.
26. Lappalainen, M., M. Koskiniemi, V. Hilesmaa, P. Ammala, K. Teramo, P. Koskela, M. Lebech, K. O. Raivio, and K. Hedman. 1995. Outcome of children after maternal primary infection during pregnancy with emphasis on avidity of specific IgG. Pediatr. Infect. Dis. J. 14:354-361.
27. Lebech, M., O. Andersen, N. C. Christensen, J. Hertel, H. E. Nielsen, B. Peitersen, C. Rechnitzer, S. O. Larsen, B. Norgaard-Pedersen, and E. Petersen. 1999. Feasibility of neonatal screening for Toxoplasma infection in the absence of prenatal treatment. Lancet 353:1834-7.
28. Li, S., G. Galvan, F. G. Araujo, Y. Suzuki, J. S. Remington, and S. Parmley. 2000. Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens. Clin. Diagn. Lab. Immunol. 7:781-787.
29. Montoya, J. G., and O. Liesenfeld. 2004. Toxoplasmosis. Lancet 363:1975-1976.
30. Nielsen, H. V., D. R. Schmidt, and E. Petersen. 2005. Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child immunoglobulin g profiles. J. Clin. Microbiol. 43:711-715.
31. Pelloux, H., P. Ciapa, A. Goullier-Fleuret, and P. Ambroise-Thomas. 1993. Evaluation du systeme VIDAS pour le diagnostic serologique de la toxoplasmose. Ann. Biol. Clin. 50:875-878.
32. Petersen, E., A. Pollak, and I. Reiter-Owona. 2001. Recent trends in research on congenital toxoplasmosis. Int. J. Parasitol. 31:115-144.
33. Pietkiewicz, H., E. Hiszyska-Sawicka, J. Kur, E. Petersen, H. V. Nielsen, M. Stankiewicz, I. Andrzejewska, and P. Myjak. 2004. Usefulness of Toxoplasma gondii recombinant antigens in serodiagnosis of human toxoplasmosis. J. Clin. Microbiol. 42:1779-1781.
34. Pinon, J. M., C. Chemla, I. Villena, F. Foudrinier, D. Aubert, D. Puygauthier-Toubas, B. Leroux, D. Dupouy, C. Quereux, M. Talmud, T. Trenque, G. Potron, M. Pluot, G. Remy, and A. Bonhomme. 1996. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme- linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J. Clin. Microbiol. 34:579-583.
35. Pinon, J.M., H. Dumon, C. Chemla, J. Franck, E. Petersen, M. Lebech, J. Zufferey, M.H. Bessieres, P. Marty, R. Holliman, J. Johnson, V. Luyasu, B. Lecolier, E. Guy, D.H. Joynson, A. Decoster, G. Enders, H. Pelloux, and E. Candolfi. 2001. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J. Clin. Microbiol. 39:2267-2271.
36. Remington, J.S., F.G. Araujo, and G. Desmonts. 1985. Recognition of different Toxoplasma antigens by IgM and IgG antibodies in mothers and their congenitally infected newborns. J. Infect. Dis. 152:1020-1024.
37. Remington, J. S., R. McLeod, P. Thuillez, and G. Desmonts. 2001. Toxoplasmosis, p. 205-346. In 3. S. Remington and J. Klein (ed.), Infectious diseases of the foetus and newborn infant, 5th ed. W.B. Saunders, Philadelphia, Pa.
38. Robert-Gangneux, F., M.F. Gavinet, T. Ancelle, J. Raymond, C. Tourte-Schaefer, and J. Dupouy-Camet. 1999. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J. Clin. Microbiol. 37:2893-2898.
39. Romand S., M. Wallon, J. Franck, P. Thulliez, F. Peyron, and H. Dumon. 2001. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet. Gynecol. 97:296-300.
40. Suzuki, Y., R. Ramirez, C. Press, S. Li, S. Parmley, P. Thulliez, and J.S. Remington. 2000. Detection of immunoglobulin M antibodies to P35 antigen of Toxoplasma gondii for serodiagnosis of recently acquired infection in pregnant women. J. Clin. Microbiol. 38:3967-3970.
41. Thalib L., L. Gras, S. Romand, A. Prusa, M.H. Bessieres, E. Petersen, and R. E. Gilbert. 2005. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. Br. J. Obstet. Gynaecol. 112:567-574.
42. Villena, I., D. Aubert, B. Leroux, D. Dupouy, M. Talmud, C. Chemla, T. Trenque, G. Schmit, C. Quereux, M. Guenounon, M. Pluot, A. Bonhomme, and J. M. Pinon. 1998. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Scand. J. Infect. Dis. 30:295-300.
43. Wallon, M., L. Kodjikian, C. Binquet, J. Garweg, J. Fleury, C. Quantin, and F. Peyron. 2004. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567-1572.